CPB2, carboxypeptidase B2, 1361

N. diseases: 148; N. variants: 11
Disease: Blood Coagulation Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005779
Disease: Blood Coagulation Disorders
Blood Coagulation Disorders 		0.040 Biomarker group BEFREE We investigated different thrombin activatable fibrinolysis inhibitor (TAFI)-related variables in patients with severe hemophilia A and their possible correlation with bleeding tendency. 31571361 2020
CUI: C0005779
Disease: Blood Coagulation Disorders
Blood Coagulation Disorders 		0.040 AlteredExpression group BEFREE Performing TAFI levels in thalassemic patients could help to detect the early coagulopathy in these patients and hence these patients can be closely monitored for any evidence of thrombosis. 27487812 2017
CUI: C0005779
Disease: Blood Coagulation Disorders
Blood Coagulation Disorders 		0.040 AlteredExpression group BEFREE The higher proCPU levels in the patients may even modestly counteract the bleeding tendency. 19038242 2009
CUI: C0005779
Disease: Blood Coagulation Disorders
Blood Coagulation Disorders 		0.040 Biomarker group BEFREE This review will discuss the role of TAFI in the regulation of fibrinolysis and detail its regulation of activation and its potential therapeutic applications in thrombotic disease and bleeding disorders. 16960106 2006